Aims To present and discuss a comprehensive and ready to use prediction model of risk of death after myocardial infarction based on the very recently concluded follow-up of the large GISSI-Prevenzione cohort and on the integrated evaluation of different categories of risk factors: those that are non-modifiable, and those related to lifestyles, co-morbidity, background, and other conventional clinical complications produced by the index myocardial infarction.
Aims To present and discuss a comprehensive and ready to use prediction model of risk of death after myocardial infarction based on the very recently concluded follow-up of the large GISSI-Prevenzione cohort and on the integrated evaluation of different categories of risk factors: those that are non-modifiable, and those related to lifestyles, co-morbidity, background, and other conventional clinical complications produced by the index myocardial infarction.
Methods
The 11 324 men and women recruited in the study within 3 months from their index myocardial infarction have been followed-up to 4 years. The following risk factors have been used in a Cox proportional hazards model: non-modifiable risk factors: age and sex; complications after myocardial infarction: indicators of left ventricular dysfunction (signs or symptoms of acute left ventricular failure during hospitalization, ejection fraction, NYHA class and extent of ventricular asynergy at echocardiography), indicators of electrical instability (number of premature ventricular beats per hour, sustained or repetitive arrhythmias during 24-h Holter monitoring), indicators of residual ischaemia (spontaneous angina pectoris after myocardial infarction, Canadian Angina Classification class, and exercise testing results); cardiovascular risk factors: smoking habits, history of diabetes mellitus and arterial hypertension, systolic and diastolic blood pressure, blood total and HDL cholesterol, triglycerides, fibrinogen, leukocytes count, intermittent claudication, and heart rate. Multiple regression modelling was assessed by receiver operating characteristic (ROC) analysis. Generalizability of the models was assessed through cross validation and bootstrapping techniques.
Population and Results
During the 4 years of follow-up, a total of 1071 patients died. Age and left ventricular dysfunction were the most relevant predictors of death. Because of pharmacological treatments, total blood cholesterol, triglycerides, and blood pressure values were not significantly associated with prognosis. Sex-specific prediction equations were formulated to predict risk of death according to age, simple indicators of left ventricular dysfunction, electrical instability, and residual ischaemia along with the following cardiovascular risk factors: smoking habits, history of diabetes mellitus and arterial hypertension, blood HDL cholesterol, fibrinogen, leukocyte count, intermittent claudication, and heart rate. The predictive models produced on the basis of information available in the routine conditions of clinical care after myocardial infarction provide ready to use and highly discriminant criteria to guide secondary prevention strategies.
Conclusions and Implications
Besides documenting what should be the preferred and practicable focus of clinical attention for today's patients, the experience of GISSI-Prevenzione suggests that periodically and prospectively collected databases on 'naturalistic' cohorts could be an important option for updating and verifying the impact of guidelines, which should incorporate the different components of the complex profile of cardiovascular risk. The GISSI Prevenzione risk function is a simple tool to predict risk of death and to improve clinical management of subjects with recent myocardial infarction. The use of predictive risk algorithms can favour the shift from medical logic, based on the treatment of single risk factors, to one
Introduction
Individual patients reflect a combination of biological characteristics and clinical features that influence prognosis, and these components must be appropriately weighted to produce an accurate assessment of risk of future events [1, 2] . Risk assessment and prognostic stratification has become widespread in the last few years [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The Coronary Risk Chart proposed by the 'Second Joint Task Force of European and other Societies on Coronary Prevention' [4] and the global risk assessment scoring of the American Heart Association and the American College of Cardiology [5] were based on the Framingham algorithm to assess the long-term risk of coronary artery disease in primary prevention [10] . In a different area, the GUSTO and GISSI groups developed multivariate statistical models for short term risk assessment of patients with acute myocardial infarction [11, 12] . Currently, no long-term predictive algorithm is available for secondary prevention of coronary heart disease. To be broadly useful and to avoid undue emphasis on individual risk factors rather than on the overall level of risk, a risk assessment algorithm should include all relevant clinical prognostic indicators and should be derived from a population representing the patients seen routinely in clinical practice [2] [3] [4] [5] [13] [14] [15] [16] [17] [18] [19] . In the case of patients after myocardial infarction, therefore, cardiovascular risk factors as well as complications after myocardial infarction (e.g. left ventricular dysfunction, electrical instability, residual ischaemia) should be considered simultaneously.
The aim of this paper is to present and discuss a simplified, updated, prediction model of risk of death up to 4 years after myocardial infarction in a Mediterranean population. For this purpose, the database of the GISSI-Prevenzione study on myocardial infarction survivors, which was entered into a program of cardiovascular prevention, has been analysed taking into account multiple characteristics -including age, sex, medical history, heart function measurements, and conventional risk factors [20] . To favour comparisons and generalizability and improve ease of use, we have produced three complementary tools: (a) a global risk assessment score; (b) a mathematical risk equation to be used for computer programs; and (c) a risk chart to allow a graphical representation.
Patients and methods

Patients
The design and data collection methods of the GISSIPrevenzione study have been published [20] . Briefly, GISSI-Prevenzione was a multicentre, pragmatic, population-oriented clinical trial aimed at testing the effectiveness of n-3 polyunsaturated fatty acids (1 g daily) and vitamin E (300 mg daily) in addition to dietary advice and current secondary preventive strategies in 11 324 men and women with recent myocardial infarction (c3 months) and without unfavourable short-term prognosis (e.g. severe congestive heart failure irrespective of adequate treatment, cancer, etc). Broad recruitment criteria were adopted for the study. In particular, only patients' unwillingness, known allergy to fish oil, mental or physical disorders substantially affecting the patient's compliance, and known congenital coagulation defects were exclusion criteria from the study, no age-limit was established. The results of GISSI-Prevenzione indicate that in patients who have had a myocardial infarction, n-3 PUFA supplements, but not a moderate dose of synthetic vitamin E, reduce long-term complications of myocardial infarction to a clinically important extent. In particular, the combined primary end-point of death, non-fatal myocardial infarction, and non-fatal stroke was significantly reduced by n-3 PUFA treatment, relative risk reduction (RRR) 15%, 95% confidence interval (CI) 2% to 26%. All the benefit seen in the combined end-point, however, was attributable to the reduction of total mortality (relative risk reduction 20%, 95% CI 6% to 23%), the rate of non-fatal cardiovascular events (myocardial infarction and stroke) being unchanged. The adoption of broad recruitment criteria as well as the involvement of a country-wide network of 172 participating centres (130 cardiological departments and 42 rehabilitation centres) across Italy in the framework of a public health system, in addition, were specifically appropriate to assess the effectiveness of tested treatments in clinical practice as well as to assure the transferability of results.
Of all the patients recruited from October 1993 to September 1995 in the GISSI-Prevenzione study and followed-up to 4 years, only 76 patients have been excluded from the current analysis because of missing values for more than 50% of their variables. Total mortality was adopted as the least controversial outcome measure [21] .
Clinical definitions
As a validation and an extension of the already available GISSI-2 stratification algorithm for the first 6 months after myocardial infarction [22] [23] [24] [25] [26] , we started the modelbuilding strategy by assessing the current long-term (4 years) prognostic value of indicators of cardiac complications after myocardial infarction, such as congestive heart failure, residual ischaemia after myocardial infarction, and electrical instability together with other indicators of cardiovascular risk.
Data collection was performed according to well established criteria already adopted in previous GISSIstudies [22] [23] [24] [25] [26] . Initial clinical, laboratory, and instrumental evaluation of patients recruited in the study were carried out at the baseline visit, i.e. either at discharge from hospital or within 3 months after the index event. Information on laboratory measurements was obtained at baseline and during follow-up (0, 6, 12, 18, 30, 42 months after recruitment). A two-dimensional echocardiographic examination was done to assess segmental left ventricular systolic function. The ejection fraction was calculated from left ventricular two-dimensional tomograms either by the area-length method or by modified Simpson's rules [27] . Evaluation of the segmental left ventricular performance pattern, as assessed by participating cardiologists, was used to generate an infarct size index expressed as the percentage of akinetic or dyskinetic segments. This functional index indirectly reflects the left ventricular function as it is dependent on the degree of overall myocardial damage caused by ischaemia or infarction. Spontaneous post-infarction angina was defined as the occurrence of a typical ischaemic chest pain manifesting at rest or at minimal exercise 24 h or more after onset of acute myocardial infarction; transient ST segment depression or elevation of 1 mm or more or inversion or pseudonormalization of the T wave during the episode of chest pain also was required for this diagnosis. The development of angina during exercise or the appearance of ST segment depression of 1 mm or more 0·08 s after the J point was taken as evidence of a positive exercise test (i.e. effort residual ischaemia). The angina threshold and the occurrence of ST segment changes were expressed in watts (bicycle ergometer) or in minutes of exercise (treadmill). The exercise test was defined as maximal if the patients reached 85% of the predicted heart rate for age or submaximal if the patient did not reach this target. Submaximal testing without ECG signs and/or symptoms of residual ischaemia were not considered diagnostic.
Twenty-four hour Holter recordings were performed and analysed peripherally by participating cardiac care unit personnel, and the following data were reported in the study forms: number of premature ventricular beats per hour, presence of sustained and/or repetitive complex ventricular arrhythmias (couplets, runs, or ventricular tachycardia), sustained and/or repetitive atrial tachyarrhythmias.
Statistical analysis
The following variables were evaluated with multivariable analysis based on the Cox proportional hazards model:
(a) Not-modifiable risk factors: age and sex; (b) Complications after myocardial infarction: indicators of left ventricular dysfunction (signs or symptoms of acute left ventricular failure during hospitalization, ejection fraction, NYHA class and extent of ventricular asynergy at echocardiography); indicators of electrical instability (number of premature ventricular beats per hour, sustained or repetitive arrhythmias during 24-h Holter monitoring); indicators of residual ischaemia (spontaneous angina pectoris, Canadian Angina Classification class, and exercise testing: ineligibility because of cardiac reasons, negative, not diagnostic, maximal or submaximal positive for symptoms or ST segment depression, and low work capacity defined as a workload less than 100 watts on bicycle ergometer or 6 min on treadmill); (c) Cardiovascular risk factors: smoking habits (smokers before myocardial infarction who gave up because of the index event were considered as nonsmokers), history of diabetes mellitus and arterial hypertension, systolic and diastolic blood pressure, blood total and HDL cholesterol, triglycerides, fibrinogen, leukocytes count, intermittent claudication, and heart rate.
Acute left ventricular failure, functional status (NYHA class), left ventricular ejection fraction, and extent of ventricular asynergy were separately included into multivariate models including age and all the individual indicators for electrical instability and residual ischaemia. The same approach was adopted for the other indicators of complications after myocardial infarction. To decrease the extent of dilution bias and of regression-to-the-mean phenomenon, mean values during the study (at baseline and at 6, 12, 18, 24, 36, and 42 months after inclusion in the study) instead of baseline values only, were used for blood lipids, leukocyte count and fibrinogen values. This approach mimics more closely long-term, usual levels and leads to associations of each factor with the outcome, which are substantially stronger than the corresponding associations with baseline levels [28, 29] . Information on arterial blood pressure and heart rate was collected only at baseline. The predictive value of blood lipids, blood pressure values, leukocyte count, fibrinogen, and heart rate was assessed in five categories choosing clinically meaningful cut-off values to approximate quintiles of population.
With the exclusion of gender, GISSI-Prevenzione data fit the proportionality assumption required for
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proportional hazards models. Therefore, two separate models were built for males and females to predict absolute risk (i.e. probability) of death over the first 4 years after myocardial infarction. The mathematical function produces an estimate of the 4-year risk of death after myocardial infarction, and as a probability it varies from 0 to 1.
The final predictive models were developed by using risk factors and indicators of complications after myocardial infarction, which were relevant predictors of risk of death after myocardial infarction. Categories of variables showing similar relative risks were collapsed together to improve the usability of the equations as well as to avoid overfitting. The fitted proportional hazards models and the fitting of unconditional multivariable logistic models, in addition, gave similar results.
Global risk assessment score
To produce a global risk assessment score similar to the one proposed from the American Heart Association and the American College of Cardiology [5] , we built a simple score system for all indicators of risk. After collapsing together levels of continuous variables with similar risk, we assigned points for each risk factor which were weighted proportionally to the value of the -coefficients of the multivariate analysis. The risk assessment score was obtained by summing all the individual points. The risk predicted by a model with the global risk assessment score as a continuous explanatory variable was used to compute 17 score categories at progressively increasing risk of death. The predictive ability to assess the 4-year absolute risk of death, and the corresponding relative risks, have been expressed for each given set of risk factor levels as a single score number.
Graphical risk chart
To allow a graphical depiction of the risk function similar to the one developed by the European Society of Cardiology [4] , we built a simple score system for 'classical' cardiovascular risk factors (including intermittent claudication, leukocyte count, HDL-cholesterol, fibrinogen levels, smoking habits, heart rate, diabetes, and hypertension) using the same scoring system as above. After summing up the points of each cardiovascular risk factor, the predictive value of this simplified score was evaluated into five categories, each one approximately doubling the risk of death: class I (c 3 points, reference group), class II ( 2 to 0 points), class III (1 to 5 points), class IV (6 to 10 points), and class V (d11 points). The risk of males and females predicted by the latter predictive model, which included terms for age and complications after myocardial infarction, was used to compute ten categories of patients at progressively increasing risk of death. Eventually, the predictive ability to assess the 4-year absolute risk of death was depicted graphically, with changing colours showing the increasing of risk.
Accuracy and generalizability
Prognostic systems should be evaluated as to accuracy (the degree to which predictions match outcomes) and generalizability (the ability to provide accurate predictions in different samples of patients) [19] . Inaccuracy may be manifest either as errors in calibration (the predicted probability may be too high or too low) or as errors in discrimination (relative ranking of individuals may be out of order).
As to accuracy, the calibration of the model was assessed by evaluating expected to observed outcomes across deciles of risk, whereas discrimination was measured as the area under the receiver operating characteristic (ROC) curve [30] . Age-adjusted Cox proportional hazards regression and the C statistic were used to test the relation between various independent variables and outcomes and to evaluate the discriminatory ability of prediction models [31] [32] [33] [34] . As to generalizability, the predictive performance of the model and the extent of overfitting were assessed through internal validation, i.e. cross validation and bootstrapping (details in appendix) [35] . All P values were two-sided. All computations, including cross and bootstrap validation, have been carried out using the SAS statistical package (SAS Institute Inc., Cary, NC, U.S.A.) [36] .
Results
During 4 years of follow-up, we recorded 1071 deaths from any cause. Subjects in GISSI Prevenzione appeared to be a broad, relatively low-risk population of acute myocardial infarction survivors recruited early after the index event: 50% of subjects were recruited within 16 days after myocardial infarction, mean age was 59 years (SD 11), 16% were aged over 70 years, 15% were females, 12% had an ejection fraction c40%. Total blood cholesterol levels were almost normally distributed at recruitment with a mean of 211 42 mg%. Arterial hypertension, diabetes mellitus, and claudication were present in 36%, 15%, and 4% of patients, respectively. Forty percent of patients smoked before the index events and only one third of them were still smoking thereafter.
Patients recruited in the study received lifestyle recommendations, and up-to-date preventive interventions. At the end of the study, in addition to the drugs tested in the trial, antiplatelet drugs, -blockers, ACE-inhibitors, and lipid-lowering drugs were prescribed to 83%, 38%, 39%, and 46% of patients, respectively. Finally, 5% of patients had coronary artery bypass graft or angioplasty procedures before recruitment and a total of 24% of patients had been revascularized at the end of the study. Table 1 shows the results when selected indicators for left ventricular dysfunction, residual ischaemia, and electrical instability were entered into separate models for men and women. As indicators of left ventricular dysfunction, acute left ventricular failure, functional status (NYHA class), left ventricular ejection fraction, and extent of ventricular asynergy were separately evaluated and significantly predicted a high 4-year risk of death.
Indicators of complications after myocardial infarction
Among the indicators of electrical instability, the number of premature ventricular beats at 24-h ambulatory ECG monitoring was the best prognostic predictor.
As expected, a contraindication to exercise test and low work capacity were predictive of prognosis [22] . Positive exercise tests (maximal or submaximal, symptom-or ST segment change-limited) were not significantly associated to 4-year prognosis in women. The prognostic value of the exercise stress test is likely to be influenced by the higher rate of patients undergoing coronary revascularization early after recruitment in patients with as compared to patients without, a positive exercise test (0-3 months: 14·1% vs 4·0%, 3-6 months: 9·6% vs 2·9%; 6-12 months: 6·8% vs 2·3%; 12-18 months: 2·2% vs 1·6%). Severity of angina pectoris, assessed according to the Canadian Cardiovascular Society (CCVS) classification, and clinical episodes of angina after myocardial infarction had limited predictive value. Patients with CCVS d2, however, were more likely to be revascularized early after recruitment (0-3 months: 21·7% vs 6·4%; 3-6 months: 8·5% vs 4·6%; 6-12 months: 5·0% vs 3·9%; 12-18 months: 1·4% vs 1·5%).
Role of 'classical' cardiovascular risk factors
In the second stage of development, the predictive value of continuous variables was evaluated separately in males and females with multivariable models adjusted for age and variables for complications after myocardial infarction as previously defined ( Table 2 ). The main determinant of prognosis in the GISSI-Prevenzione population was age at recruitment, the rate of death in 4 years progressively increasing from 2·0% in patients <45 years to 27·2% in patients >75 years. Even though the rate of death was higher for females (10·1%) as compared to males (9·4%), men had a 28% higher risk after allowing for the confounding effect of other risk factors.
Among the other significant indicators of risk, intermittent claudication almost tripled the risk of death in females, whereas smoking habits after myocardial infarction, history of diabetes, and of hypertension increased the risk of death up to 46% and 151% in males and females, respectively. Blood pressure values were not significantly associated with prognosis. Low HDLcholesterol level (c35 mg . dl 1 ) was significantly associated with worse prognosis, but only among men. Higher total cholesterol and triglyceride levels appeared to be somewhat inversely, even though not significantly, related to a 4-year risk of death. After adjusting for the confounding effect of cholesterol-lowering treatment, however, this association almost disappeared and therefore they were not included into the final model (data not shown). Only upper blood levels of fibrinogen (d400 mg . dl 1 ), leukocytes count (d8 10 9 . l 1 ), and heart rate (>75 beats . min 1 ) were significantly associated with prognosis when they were compared to the lower ones. Table 3 shows the final multivariate model including all the statistically significant predictors of death. We defined the presence of left ventricular dysfunction for 20·9% subjects who had an episode of acute left ventricular failure, dyspnoea on high or mild exertion, ejection fraction c40%, and extent of left ventricular asynergy d36% of the left ventricular wall [22] [23] [24] [25] [26] . Left ventricular dysfunction was significantly associated with the 4-year risk of death, and roughly doubled the risk of death. Left ventricular dysfunction was more prevalent among females (25·6%) as compared with males (20·2%). Young patients (<60 years) without left ventricular dysfunction were 84·8%.
Final risk model
Electrical instability was defined as the presence of sustained or repetitive arrhythmias, and/or 10 or more premature ventricular beats per hour. Electrical instability defined in this way was present in 23·4% of males and 23·9% of females, and it was significantly associated with worse prognosis only in male subjects.
Residual myocardial ischaemia was defined as either a positive exercise stress test, or clinical symptoms of angina pectoris (CCVS I to IV). Residual myocardial ischaemia was present in 50·5% of males and 47·1% of females and significantly predicted the risk of death in males, but not in females.
The efficacy of prediction of the final model with all the significant predictors of prognosis (Table 3) was compared with that of the simplified models of the global risk assessment score and of the graphical risk chart (Figs 1 and 2 for men and women, respectively). The final model had a high predictive capability, as illustrated by the value of the C statistic (males: C=0·774; females C=0·786) which is equal to the area under the receiver operating characteristic curve (ROC) and is a measure of the ability of the model to discriminate between patients who died or survived within 4 years after myocardial infarction. The curves of the two simplified models were nearly identical to the one of the full model. The C statistics associated with the global risk assessment score were 0·774 in men and 0·791 in women, whereas the C statistics associated with the graphical risk chart were 0·764 in men and 0·768 in women. The predictive performance of the full model was internally validated through cross validation and bootstrapping. The correction coefficient to the ROC curve (over-optimism) with the bootstrap technique was only 0·006 (from 0·774 to 0·768) for males and 0·027 (from 0·786 to 0·759) for females. Similar results were obtained with cross-validation. As a consequence, the final predictive model of Table 3 had no need to be adjusted for over-optimism. The mathematical equation is given in the appendix along with an example for its use. Details of validation procedures as well as final predictive equations for men and women are given in the appendix.
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Global risk assessment score
For initial assessment, measurements of serum levels of HDL-cholesterol, fibrinogen, and leukocytes count are required (Table 4) . Absolute risk (i.e. the percentage likelihood of death over 4 years) as determined for 
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GISSI-Prevenzione scoring is given in the right-hand column of Fig. 3(a) and (b). Relative risk estimates (i.e. the ratio of the absolute risk of a patient to that of a low-risk one) for each age range are compared with baseline risk conferred by age alone in the absence of other prognostic factors. The absolute risk of low-risk subjects is given at the top of each age column and indicates the 4-year risk of death for a person of the same age, without complications after myocardial infarction (i.e. left ventricular dysfunction, residual ischaemia, and electrical instability), no intermittent claudication, hypertension, or diabetes, a non-smoker, and with HDL-cholesterol >55 mg . dl 1 , fibrinogen <400 mg . dl 1 , leukocytes count <7 10 9 . l 1 , and heart rate between 65-69 pulses per minute for females and c64 pulses per minute for males. The average risk for the GISSI Prevenzione population in each age group is given in the second row. Gradations of increasing relative risk are given in colour: black cells indicate subjects at median risk; green, yellow, and red cells indicate subjects in the lower, intermediate, and higher tertile of risk; respectively. The distribution of the GISSI-Prevenzione scores in young patients was skewed towards higher risk values, with majority of patients having a low 4-year risk of death. In addition to absolute risk estimate, relative risk can be useful in providing the physician as well as the patient with an immediate frame of reference, to give a perspective of the overall risk status relative to one of low risk. Figure 3 (a) and (b) show clearly that the level of absolute risk definitely increases with age, whereas the relative risk associated with a given set of risk factors levels (defined as a single GISSI-Prevenzione score number) declines with advancing age. Absolute baseline risk can vary among different populations, whereas relative risk estimates are more stable and appear to be similar among different populations [2, 4, 5, 37, 38] . Therefore, the use of relative risk estimates can be useful also to further increase the generalizability of the GISSI-Prevenzione risk function.
Graphical mortality risk chart
As to the simplified cardiovascular risk factor score, the observed rate of death progressively increased from 4·0% in patients with the lowest score class to 23·7% in patients with a score of risk factors d11. Ten groups at progressive risk were then computed by using the simplified score of 'classical' cardiovascular risk factors along with age and complications after myocardial infarction into separate statistical models for males and females without hampering their predictive capability (Fig. 4) .
Almost 40% of patients with recent myocardial infarction belong in the first four low-risk groups (death rate less than 1% per year) which are formed mainly by patients under 60 years of age (87·2%) and without left ventricular dysfunction (95·5%). The fifth and sixth categories (about 30% of the population) are at intermediate risk (death rate about 2% per year) and are constituted by either young patients (38%) with left ventricular dysfunction (one out of three) or patients of any age (62%) with an accumulation of risk conditions other than ventricular dysfunction. The last 30% of patients belong in the higher four categories and are formed by subjects at high risk because of ventricular dysfunction (45·1%), age (>60 years: 84·5%), and the aggregation of various risk factors or clinical figures.
The ten categories of progressive 4-year risk of death have been depicted in a risk chart (Fig. 5) showing the risk of patients with a given set of prognostic factors with various colours. The first five low-risk categories 
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have been depicted with progressively lightening colours, from the lowest risk class (purple: 4-year death rate c2·0%) to the fifth class (white: 4-year death rate 5·1%-7·5%). The second half of the risk categories have been depicted with progressively darkening colours, from light beige for the sixth class (4-year death rate 7·6%-10·0%) to the highest one (dark red: 4-year death rate >30%). An individual's absolute 4-year risk of death after myocardial infarction is found by reading off the appropriate box in the chart. The first step is to calculate the individual's score for risk factors, then find the table for their age, gender, left ventricular function, and myocardial ischaemia. Within the table, the final step is to find the cell corresponding to the presence/ absence of electrical instability and to the score of risk factors. An example of such calculations is given in the appendix.
Discussion
Our paper could be summarized under three main headings: (1) prediction of prognosis after myocardial infarction; (2) applicability of predictive risk functions; (3) research and public health perspectives.
Prediction of prognosis after myocardial infarction
The use of databases derived from very large clinical trials, as a prognostic high value informative source besides the classical population-based cohorts has widely increased in recent years, especially for cardiovascular prevention and treatment [2] [3] [4] [5] [6] [7] [8] [9] 37] . The exercise proposed with the GISSI Prevenzione cohort is oriented to secondary prevention of coronary heart disease many years after the first secondary prevention trials with beta-blockers and following also the more recent trials with thrombolytics, statins, and ACE-inhibitors [38, 39] . Our results confirm, update, and extend to 4 years the predictive value of the variables included in the prognostic stratification algorithm of the GISSI-2 study [22] . Specific interesting features of this work pertain to its content as well as the methodological approach. The use of a large, recent, pragmatic, country-wide, population trial database allows a current, realistic assessment of absolute risk of death after myocardial infarction in clinical practice, largely adopting updated prevention interventions. Methodological and statistical constraints have been shaped as close as possible to fit clinical practice needs, and to facilitate the labelling of complicated patients according to broad clinical categories along with the evaluation of 'classical' risk factors. The simplification of the model either by using the most relevant indicators of complications after myocardial infarction or creating broad groups of patients with left ventricular dysfunction, electrical instability, and residual ischaemia avoids excessive tailoring of the risk function to peculiar characteristics of the GISSIPrevenzione population, facilitates its use in clinical practice, and reinforces its generalizability, as confirmed by bootstrap and cross-validation results.
As expected, age is the more important prognostic factor for death after myocardial infarction [26] . Left ventricular dysfunction, electrical instability, and clinical manifestations of myocardial ischaemia are important prognostic indicators in patients with myocardial infarction. As a diagnostic tool often preceding coronary angiography and revascularization, the prognostic value of the exercise test was somewhat hampered by revascularization procedures. In the GISSI-Prevenzione study as well as in GISSI-2 and in other databases, however, the predictive power of residual myocardial ischaemia is limited. It is worthwhile to stress that the available data indicate a much greater prognostic relevance of left ventricular dysfunction with respect to residual myocardial ischaemia after myocardial infarction, which somewhat contrasts to the rationale underlying the current risk stratification process after myocardial infarction mostly targeted to the search of critical coronary narrowing.
The significant association between intermittent claudication and prognosis indicate the need to include clinical indicators of atherosclerosis along with classical risk factors and complications after myocardial infarction to improve the predictability of the algorithm. As to gender, females had lower 4-year risk for each age group up to 60 years as compared to males and it became higher only in women aged more than 60 years. Even though complications after myocardial infarction seemed to be less predictive in women, the strength of various cardiovascular risk factors was higher for females than for males. In particular, the risk associated with smoking habits, intermittent claudication, and diabetes was definitely higher in females than in males, thus confirming the results of previous analyses of GISSI databases [25] . Our results indicate that in a population largely exposed to cholesterol-lowering treatment, HDLcholesterol but not total cholesterol and triglycerides is associated with prognosis after myocardial infarction. The limited effect of statins on HDL-cholesterol could explain the preservation of the predictive value of HDLcholesterol in patients with myocardial infarction. Diabetes is still an important risk factor, thus underlining the need for adequate control of glycaemic levels in patients with myocardial infarction. Similarly as for blood lipid values, systolic and diastolic blood pressure values did not predict mortality, whereas history of arterial hypertension was significantly associated with the risk of death. This, however, is not a new finding since it has been noted that current blood pressure values of already treated hypertensives can underestimate the risk because 'real' risk remains higher than is predicted during treatment [8, [40] [41] [42] [43] [44] . The aforementioned findings indicate that proper risk functions can estimate the residual risk due either to non-modifiable risk factors (e.g. age, sex, etc.) or to risk factors for which no effective drug or only partially effective interventions are available, or to poor pharmacological control of a given risk factor [13, 16] . Risk equations are built on a background clinical practice which influences the rate of events as well as the weight of measured (and unmeasured) risk factors [21] . Risk functions based on outdated population data could overestimate the real risk of current populations [17] [18] [19] since the rate of events recorded in older database reflects the overall influence of clinical practice attitudes available at that time. It is important to further underline that our estimates of risk should be considered as the result of clustering of risk factors and of therapeutic interventions currently performed. Any significant change of routinely therapeutic approaches could modify the actual risk pattern. The widespread use of acute and recommended interventions after myocardial infarction in our population, however, provides reassurance about the current usefulness of our risk function.
The use of 'not classical' risk factors in the GISSIPrevenzione risk function and the absence of other risk factors could be considered a strength as well as a limitation. The association of fibrinogen, leukocyte count, and heart rate with coronary heart disease risk, however, is well proven [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . The aim of risk functions is to rank individuals according to their risk, and the use of factors with no pharmacological treatment specifically directed to their correction can only improve their predictive ability. Any limitation due to the inclusion or the exclusion of selected markers of risk, however, should not be over-emphasized, since risk functions should be viewed only as pragmatic tools to increase the prognostic discernment ability of physicians. The final judgement of the overall clinical status of a patient as well as the decisions about the clinical intervention which are needed in that particular case are in the hands of the caring physician and cannot be abdicated.
The exclusion from the study of high-risk patients with severe congestive heart failure could be seen as a 
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limitation of the GISSI-Prevenzione risk function. Patients with severe congestive heart failure, however, are already known to have a serious prognosis, therefore the GISSI-Prevenzione risk function is even more helpful for the larger population of patients with myocardial infarction whose risk, because of a 'sufficiently' preserved myocardial functionality, can be assessed with much more difficulty in clinical practice.
A 4-year duration of follow-up could be seen as a limitation of the GISSI-Prevenzione function, since other predictive algorithms used longer follow-up periods. However, it has been noted that long reference period for risk calculations can be confusing and the use of shorter periods (e.g. 5 years) has been recently advocated in response to feedback from clinicians that patients have difficulty personalizing longer risk periods and because most treatment trials run for about 5 years [29, 41, 42, 57] .
Applicability of predictive risk functions
The development of three different tools to predict the risk of death after myocardial infarction allows the maximal utilization of the GISSI-Prevenzione function. The mathematical equation, in fact, can be easily incorporated in a computer program to allowing the most precise estimation of risk.
The global risk assessment score (Fig. 3) gives the opportunity to compare absolute and relative risk estimates for a given patient without using electronic calculators as well as the theoretical amount of absolute avoidable risk which could be eliminated if either more effective therapeutic interventions were to become available or more aggressive approaches were adopted. Relative risk can be estimated by comparing a given individual's estimated risk with the absolute risk of an individual at low risk (i.e. a person of the same age and (Fig. 5) is the simplest tool to forecast risk of death after myocardial infarction and gives a different perspective of view which complements the others. It allows simple estimation of the gross effect of age, gender, various risk factors, and complications after myocardial infarction, thus furnishing a correct, fast view of risk after myocardial infarction, according to the clinical status of a given patient. Risk estimates do not exactly overlap in the last two approaches (Figs 3  and 5) , even though the building of a more detailed (and complicated) risk chart gave the same results of the global risk assessment score (data not shown). In a sense, the European-like risk chart approach could be viewed as closer to the needs of clinical practice because exact risk for individual patients cannot be estimated by risk functions and it is not required for the decisionmaking procedures of modern evidence-based medicine.
Global estimates of absolute risk based on the summation of all major risk factors can be useful for identifying high-risk patients needing immediate attention and intervention, for tailoring preventive interventions according to risk estimates, and for improving patients' compliance to suggested interventions. This kind of approach has been proposed by several medical associations [2] [3] [4] [5] [6] [7] [8] [9] . Relative risk (i.e. the ratio of the absolute risk of a given patient or of a group of patients to that of a low-risk one) is not easy to understand and could over-estimate the real risk [2, 4, 5, 15] . Relative reductions of risk by lowering blood pressure or blood cholesterol, for instance, are 'similar for all patients at all ages up to about 75-80 years' [2, 29, 57, 58] .
Having being prepared as a tool for clinical practice, the GISSI-Prevenzione risk function can be also used to develop guidelines for the management of patients with myocardial infarction. For example, the National Cholesterol Education Program places increased emphasis on the absolute-risk calculation to guide considerations on when to use cholesterol-lowering drugs in primary prevention. The Italian National Association of Hospital Cardiologists (ANMCO) adopted the 18-month GISSI-Prevenzione risk function to propose an easy therapeutic algorithm targeted at cholesterol values as well as at the overall risk of individuals for the management of hypercholesterolaemia in patients with coronary heart disease [59] . Validity of risk functions should be evaluated in the light of a number of factors (Table 5 ) which could limit the extrapolation to other populations [21] . Strictly speaking, the GISSI-Prevenzione function should be used only to estimate current, absolute 4-year risk of death in Mediterranean patients with myocardial infarction. We expressed elsewhere concern for the extrapolation of risk functions derived from the Framingham population to Mediterranean Countries in which the scenario could be more complex and the existence of either protective factors (reducing the risk of coronary heart disease) or of competing causes of death (reducing the burden of disease attributable to risk factors like cholesterol) should be considered [13] [14] [15] . Mediterranean dietary habits provide a protective background against the cholesterol-specific risk. Increased intake of unsaturated fatty acids or antioxidant substances could be protective and an equilibrium between risk and protective factors could actually exist [4, [13] [14] [15] [16] 20] . The GISSI-Prevenzione is representative of such different areas and, provided Table 5 Potential uses and limitations of risk functions resemblance to the GISSI-Prevenzione population, the risk function can be extrapolated to other populations at relatively low-risk for coronary heart disease events. However, it is likely that the occurrence of myocardial infarction decreases the amount of background differences of patients across different countries. If it were true, then GISSI-Prevenzione function could be widely adopted to predict risk after myocardial infarction.
Research and public health perspectives
The overwhelming importance of age in conditioning prognosis after myocardial infarction clearly indicates the need for clinical trials focused on older individuals as well as to invert the attitude of excluding the elderly from even cheap effective therapies [25, [60] [61] [62] [63] [64] [65] [66] . According to our risk estimates, absolute net benefits that could be obtained by pharmacological treatments would indicate the elderly as a preferred target population, whereas the cost/benefit ratio could be seen as unfavourable in young, relatively low-risk subjects. On the other hand the life expectancy of young people could be significantly prolonged by preventive strategies, even though the cost of this benefit would not be negligible. This is a clearly unsolved problem in public health and, as a consequence, more in-depth information on the effectiveness of therapeutic interventions is urgently needed to provide evidence-based evaluations of risk/benefit and cost/benefit ratios in the elderly as well as in young patients.
During the last ten years, several large-scale clinical trials have produced an enormous amount of information on the treatment and prevention of coronary heart disease and its consequences [4, 5, 20, 38, 39] . The so-called megatrials have addressed interesting issues in various clinical settings, resulting in effective interventions or similarly effective treatments [38] . Such a productive period greatly helped the comprehension and treatment of coronary heart disease. Today several interventions are available but their effectiveness as well as practicability and acceptance in the long-run have not been fully tested. Physicians have to tailor the best therapeutic approach to each individual to maximize the degree of achievable protection as well as long-term compliance. Such objectives should be pursued at the most favourable cost/ and risk/benefit ratios. Instead of using an empirical, arbitrary approach, it is advisable to organize clinical trials to test the efficacy of comprehensive therapeutic strategies aimed at reducing the risk of patients as a whole (i.e. testing the additivity of benefit from available therapeutic options). With this in mind, risk functions could be very useful to stratify a priori patients according to their expected risk and then randomly allocate different aggressive treatment strategies.
Conclusions
The GISSI Prevenzione risk function is a simple tool to predict risk of death after myocardial infarction. It can be used to improve clinical management of subjects with recent myocardial infarction. This is also a cultural operation aimed at favouring the shift from medical logic, based on the treatment of single risk factors, to one centred on the patient as a whole as well as on the tailoring of medical interventions according to his/her overall risk. Clinical trials testing comprehensive care strategies in patients at different levels of risk should be implemented to help physicians find out the best, costeffective therapeutic strategy for each patient, among the many efficacious treatments which are currently available.
Appendix
Internal validation of the predictive model
With cross validation, data were split into 10 equal-sized parts, then the model using 90% of data was fitted, and the resulting model was tested (calculating the ROC curve) on the remaining 10% of data. This process was repeated excluding progressively each of the selected parts. The difference between the ROC curve estimated using 100% of data and the mean value of the 10 measures of the ROC curves after cross-validation estimated the parameter 'over-optimism', i.e. a measure of the extent to which the predictive accuracy of the model based on the full set of data was over-optimistic.
With bootstrapping (sampling of individual subjects with replacement), 200 bootstrap samples each constituted by 11 248 subjects were generated from the full set of data. The ROC curve and the -coefficients were calculated from each sample; the difference between mean values of these ROC curves, and mean values of the ROC curves obtained when the -coefficients for each bootstrap sample were applied to the original sample, gave the bootstrap estimate of over-optimism.
Application of the full model
The -coefficients for males and females given in Table 6 are used to compute the 4-year probability of death: P=1 s(t) B where s(t) is the survival function at time t, and B is the relative odds for death. In GISSIPrevenzione, S(t) at 4 years is equal to 0·932932 for men, and to 0·934174 for women. The relative odds for death can be calculated as B=exponential(L-G). The quantities L and G for a given patient can be calculated as follows: (1) . l 1 ). The same is for women, using the appropriate -coefficients (Table 6 ). (2) G is the same function evaluated at the values of the means for each variable. In GISSI-Prevenzione, G (men)=0·726832 and G (women)=1·350553.
Example
A patient with the following characteristics: male, 60 years old, with residual myocardial ischaemia but with no left ventricular dysfunction or electrical instability; not smoker, normoglycemic, without claudication intermittens, hypertensive, with a leukocyte count <7 10 9 . l 1 , fibrinogen <400 mg . dl 1 , HDL cholesterol=40 mg . dl 1 , and heart rate= 70 beats . min 1 . 
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We can calculate the 4-year probability of death predicted by the full model with the following steps:
(1) L=0·195582+0·198499+0·206716+0·135530 0·275190=0·461137 (2) B=exponential(0·461137 0·726832)=0·766673 (3) P=1-0·932932 B =0·0518, which means a predicted probability of death in four years equal to 5·2%
An estimate of the probability of death can be obtained either from the global risk assessment score or the graphical risk chart. The score for this patient calculated by using the scoring system shown in Table 4 is equal to 4, which corresponds to a 4-year predicted probability of death equal to 5·4%. From the graphical risk chart given in Fig. 5 , the same patient has a score of risk factors equal to 0 and belongs to the fifth risk class, which gives a 4-year predicted probability of death ranging from 5·1% to 7·5%.
